CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?

Byung-Cheol Song, Yoo-Kyung Cho, Hyeyoung Jwa, Eun Kwang Choi, Heung Up Kim, Hyun Joo Song, Soo-Young Na, Sun-Jin Boo, Seung Uk Jeong

Clin Mol Hepatol. 2014;20(4):355-360. Published online 2014 December 24 DOI: https://doi.org/10.3350/cmh.2014.20.4.355

Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?

Byung-Cheol Song, Yoo-Kyung Cho, Hyeyoung Jwa, Eun Kwang Choi, Heung Up Kim, Hyun Joo Song, Soo-Young Na, Sun-Jin Boo, Seung Uk Jeong

Clinical and Molecular Hepatology. 2014;20(4):355

Link1 Link2 Link3

Quantitative serum HBsAg and HBeAg are strong predictors of sustained HBeAg seroconversion to pegylated interferon alfa-2b in HBeAg-positive patients

Hui Ma, Rui-feng Yang, Lai Wei

Journal of Gastroenterology and Hepatology. 2010;25(9):1498-1506

Link1 Link2

Prediction of spontaneous HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients during the immune clearance phase

Guangjun Song, Huiying Rao, Bo Feng, Lai Wei

Journal of Medical Virology. 2014;86(11):1838-1844

Link1 Link2

Baseline serum hepatitis B core antibody level predicts HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B after antiviral treatment

Xiang-an Zhao, Jian Wang, Jiacheng Liu, Guangmei Chen, Xiaomin Yan, Bei Jia, Yue Yang, Yong Liu, Da Gu, Zhaoping Zhang, Xiaoxing Xiang, Rui Huang, Chao Wu

Antiviral Research. 2021;193:105146

Link1 Link2

Current treatments for patients with HBeAg-positive chronic hepatitis B virus infection: a comparison focusing on HBeAg seroconversion

George K. K. Lau

Liver International. 2010;30(4):512-520

Link1 Link2

HBV genotype B is associated with better response to interferon therapy in HBeAg( + ) chronic hepatitis than genotype C

Chun Tao Wai, Chi-Jen Chu, Munira Hussain, Anna S. F. Lok

Hepatology. 2002;36(6):1425-1430

Link1 Link2 Link3

Effects of IFN monotherapy versus combined therapy on HBeAg seroconversion or seroclearance in HBeAg-positive chronic hepatitis B patients: A meta-analysis

Feng Zhu, Qiongfang Zhang, Qiongyue Zhang, Dazhi Zhang

Microbial Pathogenesis. 2020;139:103912

Link1 Link2

49 Association between HBeAg seroconversion and sustained HBV-DNA suppression in patients treated with peginterferon alpha-2a (40KD) (PEGASYS) for HBeAg-positive chronic hepatitis B (CHB)

T. Piratvisuth, G.K.K. Lau, P. Marcellin, W.C. Chow, G. Cooksley, M.W. Fried, S.W. Paik, Y.F. Liaw, M. Popescu, P. Button

Journal of Hepatology. 2006;44:S23

Link1 Link2

Liver Histopathological Features Influencing HBeAg Seroconversion in Patients with HBeAg-positive Chronic Hepatitis B Treated with Pegylated Interferon α

Yao-ren Hu, Hua-dong Yan, Guo-sheng Gao, Cheng-liang Zhu, Ji-fang Cheng

Infection International. 2014;3(1):10-15

Link1 Link2

P1066 IMPROVED HBeAg SEROCONVERSION BY SEQUENTIAL TELBIVUDINE THERAPY FOLLOWING PARTIAL RESPONSE TO PEGYLATED INTERFERON TREATMENT IN HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS

Q. Zheng, Y.Y. Zhu, J. Chen, R.Y. Liu, J. Dong, W.D. Zeng, J.J. Jiang

Journal of Hepatology. 2014;60(1):S432

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.